Pharmacotherapy of dysthymia: Review and new findings

European Psychiatry

Volumn 13, Issue 4, 1998, Pages 203-209

  Versiani, M ^a,b   Nardi, A E ^a   Figueira, I ^a  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^b NONE   (Brazil)

Author keywords

Drug treatment; Dysthymia; Dysthymic disorder

Indexed keywords

AMISULPRIDE; AMITRIPTYLINE; ANTIDEPRESSANT AGENT; BENZAMIDE DERIVATIVE; CHLORDIAZEPOXIDE; DIAZEPAM; DOXEPIN; FLUOXETINE; IMIPRAMINE; LITHIUM; MOCLOBEMIDE; MONOAMINE OXIDASE INHIBITOR; NIMODIPINE; PHENELZINE; RITANSERIN; SEROTONIN 2A ANTAGONIST; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; SULPIRIDE; TRANYLCYPROMINE; TRAZODONE; TRICYCLIC ANTIDEPRESSANT AGENT;

AFFECTIVE NEUROSIS; ANTICHOLINERGIC EFFECT; ARTICLE; CLINICAL TRIAL; CONSTIPATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DEPRESSION; DOUBLE BLIND PROCEDURE; DRUG INDUCED DISEASE; DYSTHYMIA; HUMAN; MAJOR CLINICAL STUDY; MENTAL DISEASE; PRIORITY JOURNAL; PSYCHOPHARMACOTHERAPY; RANDOMIZED CONTROLLED TRIAL; SOMNOLENCE; TREATMENT OUTCOME; URINE RETENTION; VISUAL IMPAIRMENT; XEROSTOMIA;

EID: 0032125670     PISSN: 09249338     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0924-9338(98)80005-9     Document Type: Article

References (63)

1. 1 Anonymous. Dysthymia in clinical practice. the WPA dysthymia working group. Br J Psychiatry 1995 ; 166 : 174-83
2. 2 Akiskal H. La dysthymie et son traitement. Encephale 1993 ; 19 : 375-8
3. 3 Akiskal HS. A proposed clinical approach to chronic and "resistant" depressions: evaluation and treatment. J Clin Psychiatry 1985 ; 46 : 32-7
4. 4 Akiskal HS. Chronic depression. Bull Menninger Clin 1991 ; 55 : 156-71
5. 5 Akiskal HS. Dysthymia. clinical and external validity. Acta Psychiatr Scand Suppl 1994 ; 383 : 19-23
6. 6 Akiskal HS, Weise RE. The clinical spectrum of so-called "minor" depressions. Am J Psychother 1992 ; 46 : 9-22
7. 7 American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 3rd revised edition. Washington: American Psychiatric Press; 1987
8. 8 American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 4th edition. Washington: American Psychiatric Press; 1994
9. 9 Angst J, Wicki W. The Zurich study. XI. Is dysthymia a separate form of depression? Results of the Zurich cohort study. Eur Arch Psychiatry Clin Neurosci 1991 ; 240 : 349-54
10. 10 Ardito R, Cecchini S, Rama S. Durata del trattamento antidepressivo. Ricadute e loro prevenzione. Minerva Med 1977 ; 68 : 1667-74
11. 11 Auby P, Olivier F, Schmitt L, Peresson G, Moron P. Inhibiteurs calciques et troubles dysthymiques. Données récentes. Encephale 1992 ; 18 : 67-9
12. 12 Bakish D, Lapierre YD, Weinstein R et al. Ritanserin, imipramine, and placebo in the treatment of dysthymic disorder. J Clin Psychopharmacol 1993 ; 13 : 409-14
13. 13 Barrett JE. Naturalistic change after 2 years in neurotic depressive disorders (RDC categories). Compr Psychiatry 1984 ; 25 : 404-18
14. 14 Benichou L, Pialloux G. Lithium et dysthymies. Pratique ambulatoire, Bord Med 1972 ; 5 : 673-8
15. 15 Berbescu C. Tratamentul eu litiu in boala distimica a copilului si adolescentului. Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Neurol Psihiatr Neurochir 1996 ; 31 : 3
16. 16 Bersani G, Pozzi F, Marini S, Grispini A, Pasini A, Ciani N. 5-ht2 receptor antagonism in dysthymic disorder: a double-blind placebo-controlled study with ritanserin. Acta Psychiatr Scand 1991 ; 83 : 244-8
17. 17 Bonasegla F, Cavalca GG, Rossini R. Azione dei sali di litio sugli stati distimici in soggetti ipertiroidei. Riv Sper Freniatr 1969 ; 93 : 1328-36
18. 18 Cedrola G, Amati A, Del Vecchio M, Camardese M, Kemali D. Rilievi clinici sult'azione terapeutica del litio carbonato nelle psicosi distimiche. Osp Psichiatr 1970 ; 38 : 359-72
19. 19 Corona GL, Cucchi ML, Frattini P et al. Noradrenergic output and clinical response in depressed women during amitriptyline therapy. Pharmacopsychiatry 1989 ; 22 : 144-51
20. 20 Davidson J, Giller EL, Zisook S et al. An efficacy of isocarboxazid and placebo in depression and its relationship to depressive nosology. Arch Gen Psychiatry 1988 ; 45 : 120-7
21. 21 Dunner DL, Schmaling KB. Treatment of dysthymia: fluoxetine versus cognitive therapy. Neuropsychopharm 1994 ; 10 : 234
22. 22 Frances A, Kocsis J, Marin D, Manning D, Markowitz J, Mason B, Widiger T. Diagnostic criteria for dysthymic disorder. Psychopharmacol Bull 1989 ; 25 : 325-9
23. 23 Frances A, Voss CB. Treatment planning, dysthymic disorder complicated by bouts of major depression. Hosp Community Psychiatry 1987 ; 38 : 461-3
24. 24 Garvey MJ, Cook BL, Tollefson GD, Schaffer CB. Antidepressant response in chronic major depression. Compr Psychiatry 1989 ; 30 : 214-17
25. 25 Geisler A, Mygind O, Knudsen R, Sloth-Nielson M. Ritanserin and flupenthixol in dysthymic disorder. Nord J Psychiatry 1992 ; 46 : 237-43
26. 26 Guelfi JD, Pichot P, Dreyfus JF. Efficacy of tianeptine in anxious-depressed patients: results of a controlled multicenter trial versus amitriptyline. Neuropsychobiology 1989 ; 22 : 41-8
27. 27 Gwirtsman HE. Dysthymia and chronic depressive states: diagnostic and pharmacotherapeutic considerations. Overview of the diagnosis, prevalence, and comorbidity of dysthymia. Psychopharmacol Bull 1994 ; 30 : 45-51
28. 28 Harrison W, Rabkin J, Stewart JW, Mcgrath PJ, Tricamo E, Quitkin F. Phenelzine for chronic depression: a study of continuation treatment. J Clin Psychiatry 1986 ; 47 : 346-9
29. 29 Hellerstein DJ, Yanowitch P, Rosenthal J et al. A randomized double-blind study of fluoxetine versus placebo in the treatment of dysthymia. Am J Psychiatry 1993 ; 150 : 1169-75
30. 30 Hirschfeld RM. Major depression, dysthymia and depressive personality disorder. Br J Psychiatry Suppl 1994 : 23-30
31. 31 Hirschfeld RM, Schatzberg AF. Long-term management of depression, Am J Med 1994 ; 97 : 33S-8S
32. 32 Howland RH. Pharmacotherapy of dysthymia: a review. J Clin Psychopharmacol 1991 ; 11 : 83-92
33. 33 Howland RH. Chronic depression. Hosp Community Psychiatry 1993 ; 44 : 633-9
34. 34 Howland RH, Thase ME. Biological studies of dysthymia. Biol Psychiatry 1991 ; 30 : 283-304
35. 35 Jancar J, Gunaratne IJ. Dysthymia and mental handicap. Br J Psychiatry 1994 ; 164 : 691-3
36. 36 Keller MB. Chronic and recurrent affective disorders: incidence, course, and influencing factors. Adv Biochem Psychopharmacol 1985 ; 40 : 111-20
37. 37 Keller MB. Dysthymia in clinical practice: course, outcome and impact on the community. Acta Psychiatr Scand Suppl 1994 ; 383 : 24-34
38. 38 Keller MB. Treatment of chronic depression with sertraline or imipramine: preliminary blinded response rates. Psychopharmacol Bull 1996 ; 25 : 68-73
39. 39 Keller MB, Lavori PW, Endicott J, Coryell W, Klerman GL. "Double depression": two-year follow-up. Am J Psychiatry 1983 ; 140 : 689-94
40. 40 Keller MB, Russell CW. Refining the concept of dysthymia. Hosp Community Psychiatry 1991 ; 42 : 892-3
41. 41 Klein DN, Taylor EB, Dickstein S, Harding K. Primary early-onset dysthymia: comparison with primary nonbipolar non-chronic major depression on demographic, clinical, familial, personality, and socioenvironmental characteristics and short-term outcome. J Abnorm Psychol 1988 ; 97 : 387-98
42. 42 Kocsis JH, Frances AJ, Voss C, Mann JJ, Mason BJ, Sweeney J. Imipramine treatment for chronic depression. Arch Gen Psychiatry 1988 ; 45 : 253-7
43. 43 Kocsis JH, Friedman RA, Markowitz JC, Leon A, Miller N, Gniwesch L, Parides M. Maintenance therapy for chronic depression: a controlled clinical trial of desipramine. Arch Gen Psychiatry 1996 ; 53 : 769-74
44. 44 Kocsis JH, Sutton BM, Frances AJ. Long-term follow-up of chronic depression treated with imipramine. J Clin Psychiatry 1991 ; 52 : 56-9
45. 45 Lecrubier Y. The treatment of dysthymics with a dopaminergic presynaptic blocker. Neuropsychopharm 1994 ; 10 : 302
46. 46 Lee S. The nature of dysthymia [letter]. Br J Psychiatry 1995 ; 166 : 678
47. 47 Leon CA, Vigoya J, Conde S, Campo G, Castrillon E, Leon A. Comparacion del efecto de la amisulprida y la viloxacina en el tratamiento de la distimia. Acta Psiquiatr Psicol Am Lat 1994 ; 40 : 41-9
48. 48 Maier W, Benkert O. Treatment of chronic depression with sulpiride: evidence of efficacy in placebo-controlled single case studies. Psychopharmacology 1994 ; 115 : 495-501
49. 49 Marin DB, Kocsis JH, Frances AJ, Parides M. Desipramine for the treatment of "pure" dysthymia versus "double" depression. Am J Psychiatry 1994 ; 151 : 1079-80
50. 50 Paykel ES, Hollyman JA, Freeling P et al. Predictors of therapeutic benefit from amitriptyline in mild depression: a general practice placebo-controlled trial. J Affect Disord 1988 ; 14 : 83-95
51. 51 Ravindran AV, Bialik RJ, Lapierre YD. Therapeutic efficacy of specific serotonin reuptake inhibitors (SSRIs) in dysthymia. Can J Psychiatry 1994 ; 39 : 21-6
52. 52 Reyntjens A, Gelders YG, Hoppenbrouwers MJA et al. Thymosthenic effects of ritanserin (R55667), a centrally acting serotonin-S2 receptor blocker. Drug Dev Res 1986 ; 8 : 205-11
53. 53 Rihmer Z, Szadoczky E. Dexamethasone suppression test and trh-tsh test in subaffective dysthymia and character-spectrum disorder. J Affect Disord 1993 ; 28 : 287-91
54. 54 Rosenthal J, Hemlock C, Hellerstein DJ et al. A preliminary study of serotonergic antidepressants in treatment of dysthymia. Prog Neuropsychopharmacol Biol Psychiatry 1992 ; 16 : 933-41
55. 55 Stewart JW, Mcgrath PJ, Liebowitz MR, Harrison W, Quitkin F, Rabkin JG. Treatment outcome validation of DSM-III depressive subtypes: clinical usefulness in outpatients with mild to moderate depression. Arch Gen Psychiatry 1985 ; 42 : 1148-53
56. 56 Thase ME, Fava M, Halbreich U et al. A placebo-controlled randomized clinical trial comparing sertraline and imipramine for the treatment of dysthymia. Arch Gen Psychiatry 1996 ; 53 : 777-84
57. 57 Tyrer P, Murphy S, Kingdon D et al. The Nottingham study of neurotic disorder: comparison of drug and psychological treatments. Lancet 1988 ; 2 : 235-40
58. 58 Vallejo J, Gasto C, Catalan R, Salamero M. Double-blind study of imipramine versus phenelzine in melancholias and dysthymic disorders. Br J Psychiatry 1987 ; 151 : 639-642
59. 59 Versiani M, Nardi AE, Figueira ILV, Stabl M. Tolerability of moclobemide, a new reversible inhibitor of monoamine oxidase-A, compared with other antidepressants and placebo. Acta Psychiatr Scand 1990 ; 360 : 24-8
60. 60 Versiani M, Nardi E. Distimia: características clínicas y consecuencias. In: Fraile MG, Sánchez JE, Pichot P, eds. Avances en transtornos afectivos. Barcelona: Ediciones en Neurociencias; 1996. p 33-48
61. 61 Versiani M, Nardi E, Capponi R. Moclobemide compared with imipramine in the treatment of chronic depression (dysthymia DSM-III-R): a double-blind placebo controlled trial. Clin Neuropharmacol 1992 ; 15 : 148-9
62. 62 Ward NG, Bloom VL, Friedel RO. The effectiveness of tricyclic and depressants in chronic depression. J Clin Psychiatry 1979 ; 40 : 49-52
63. 63 Waring EM, Chamberlaine CH, Mccrank EW, Stalker CA, Carver C, Fry R, Barnes S. Dysthymia: a randomized study of cognitive marital therapy and antidepressants. Can J Psychiatry 1988 ; 33 : 96-9